Treatment of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue with fludarabine: effect on tumor microenvironment

被引:8
作者
de Boer, Jan-Paul [1 ]
Raderer, Markus [6 ]
van Tinteren, Harm [2 ]
Aleman, Berthe M. P. [3 ]
Boot, Henk [4 ]
de Jong, Daphne [5 ]
机构
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Med Oncol, NL-1066 CX Amsterdam, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Biometr, NL-1066 CX Amsterdam, Netherlands
[3] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Radiotherapy, NL-1066 CX Amsterdam, Netherlands
[4] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Gastroenterol, NL-1066 CX Amsterdam, Netherlands
[5] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
[6] Univ Vienna, Dept Internal Med 1, Div Oncol, Vienna, Austria
关键词
Fludarabine; extranodal marginal zone lymphoma; Tregs; FOXP3; B-CELL LYMPHOMA; HELICOBACTER-PYLORI ERADICATION; CHRONIC LYMPHOCYTIC-LEUKEMIA; GASTRIC MALT LYMPHOMA; REGULATORY T-CELLS; LOW-GRADE; FOLLICULAR LYMPHOMA; FOLLOW-UP; PLUS CYCLOPHOSPHAMIDE; ORAL FLUDARABINE;
D O I
10.3109/10428194.2011.607527
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastric Helicobacter pylori (HP) positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) develops during chronic antigenic stimulation with specific T-cell help. Chemotherapy that acts both on the malignant B-cells and on T-cells in the microenvironment, i.e. nucleoside analogs, might therefore be an attractive treatment. In 14 patients with gastric MALT lymphoma treated with fludarabine, alterations in T-cell subsets were studied in subsequent peripheral blood samples and in gastric biopsies. Treatment with fludarabine resulted in a steep decrease in T-cell subsets in peripheral blood samples. By contrast no decrease in T-cell populations was observed in subsequent gastric biopsy samples and a moderate increase was observed in relative infiltration with CD3(+), CD4(+) and CD8(+) cells. In addition an increase in density of FOXP3(+) cells (i.e. Tregs) was seen (p = 0.047). These alterations in different T-cell subsets were not observed in gastric biopsy samples of patients treated with HP-eradication only.
引用
收藏
页码:2262 / 2269
页数:8
相关论文
共 50 条
[1]   Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients [J].
Armitage, JO ;
Carbone, PP ;
Connors, JM ;
Levine, A ;
Bennett, JM ;
Kroll, S .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) :897-906
[2]   Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: Evaluation of minimal residual disease and CD4+lymphocytopenia after treatment [J].
Bastie, JN ;
Cazals-Hatem, D ;
Daniel, MT ;
D'Agay, MF ;
Rabian, CL ;
Glaisner, S ;
Noel-Walter, MP ;
Dabout, D ;
Flandrin, G ;
Dombret, H ;
Poisson, D ;
Degos, L ;
Castaigne, S .
LEUKEMIA & LYMPHOMA, 1999, 35 (5-6) :555-565
[3]   REGRESSION OF PRIMARY GASTRIC LYMPHOMA OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE TYPE AFTER CURE OF HELICOBACTER-PYLORI INFECTION [J].
BAYERDORFFER, E ;
NEUBAUER, A ;
RUDOLPH, B ;
THIEDE, C ;
LEHN, N ;
EIDT, S ;
STOLTE, M .
LANCET, 1995, 345 (8965) :1591-1594
[4]   State-of-the-art therapeutics: Marginal-zone lymphoma [J].
Bertoni, F ;
Zucca, E .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (26) :6415-6420
[5]   Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine [J].
Beyer, M ;
Kochanek, M ;
Darabi, K ;
Popov, A ;
Jensen, M ;
Endl, E ;
Knolle, PA ;
Thomas, RK ;
von Bergwelt-Baildon, M ;
Bebey, S ;
Hallek, M ;
Schultze, JL .
BLOOD, 2005, 106 (06) :2018-2025
[6]   A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas [J].
Brown, Jennifer R. ;
Friedberg, Jonathan W. ;
Feng, Yang ;
Scofield, Sarah ;
Phillips, Kimberly ;
Dal Cin, Paola ;
Joyce, Robin ;
Takvorian, Ronald W. ;
Fisher, David C. ;
Fisher, Richard I. ;
Liesveld, Jane ;
Marquis, Diana ;
Neuberg, Donna ;
Freedman, Arnold S. .
BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 (06) :741-748
[7]   Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy [J].
Carney, D. A. ;
Westerman, D. A. ;
Tam, C. S. ;
Milner, A. ;
Prince, H. M. ;
Kenealy, M. ;
Wolf, M. ;
Januszewicz, E. H. ;
Ritchie, D. ;
Came, N. ;
Seymour, J. F. .
LEUKEMIA, 2010, 24 (12) :2056-2062
[8]  
Cavalli F, 2001, Hematology Am Soc Hematol Educ Program, P241
[9]   Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type [J].
Conconi, A ;
Martinelli, G ;
Thiéblemont, C ;
Ferreri, AJM ;
Devizzi, L ;
Peccatori, F ;
Ponzoni, M ;
Pedrinis, E ;
Dell'Oro, S ;
Pruneri, G ;
Filipazzi, V ;
Dietrich, PY ;
Gianni, AM ;
Coiffier, B ;
Cavalli, F ;
Zucca, E .
BLOOD, 2003, 102 (08) :2741-2745
[10]   Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma [J].
Copie-Bergman, C ;
Gaulard, P ;
Lavergne-Slove, A ;
Brousse, N ;
Fléjou, JF ;
Dordonne, K ;
de Mascarel, A ;
Wotherspoon, AC .
GUT, 2003, 52 (11) :1656-1656